Artelo Biosciences's total assets for Q3 2024 were $7.14M, a decrease of -14.29% from the previous quarter. ARTL total liabilities were $775.00K for the fiscal quarter, a -24.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.